ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,353.69
-0.01%
US Tech 100
18,532.00
-0.05%
다우존스 지수
38,952.68
0.37%
Bitcoin
71,058.42
-0.03%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Praxis Precision Medicines Inc (PRAX)

  7. Praxis Precision Medicines Inc (PRAX) 뉴스

PRAX

Praxis Precision Medicines (PRAX)

Praxis Precision Medicines Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:PRAX
일자시간출처헤드라인심볼기업
2024/05/2021:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
2024/05/1321:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRAXPraxis Precision Medicines Inc
2024/05/1321:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRAXPraxis Precision Medicines Inc
2024/04/1221:00GlobeNewswire Inc.Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual MeetingNASDAQ:PRAXPraxis Precision Medicines Inc
2024/03/0523:08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PRAXPraxis Precision Medicines Inc
2024/03/0521:33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PRAXPraxis Precision Medicines Inc
2024/03/0521:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRAXPraxis Precision Medicines Inc
2024/03/0521:12Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PRAXPraxis Precision Medicines Inc
2024/02/1510:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PRAXPraxis Precision Medicines Inc
2024/02/1506:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
2024/02/1506:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
2024/02/1500:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PRAXPraxis Precision Medicines Inc
2024/02/1409:08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PRAXPraxis Precision Medicines Inc
2024/02/0106:20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PRAXPraxis Precision Medicines Inc
2024/01/1806:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
2024/01/1806:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
2024/01/1806:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
2024/01/1806:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
2024/01/1307:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRAXPraxis Precision Medicines Inc
2024/01/1307:20Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PRAXPraxis Precision Medicines Inc
2024/01/1120:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRAXPraxis Precision Medicines Inc
2024/01/1107:28Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PRAXPraxis Precision Medicines Inc
2024/01/1106:19GlobeNewswire Inc.Praxis Precision Medicines, Inc. Announces Proposed Public OfferingNASDAQ:PRAXPraxis Precision Medicines Inc
2024/01/1106:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRAXPraxis Precision Medicines Inc
2024/01/1011:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
2024/01/1011:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
2024/01/1011:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
2024/01/1011:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
2023/12/0807:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRAXPraxis Precision Medicines Inc
2023/12/0807:19Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PRAXPraxis Precision Medicines Inc
 검색 관련기사 보기:NASDAQ:PRAX

최근 히스토리

BIT
P1ZQA4
NLBNPIT1ZQA4 20240621 520
LSE
0NF3
Paion
LSE
BO77
Stan.chtd.frn
BIT
P1Z0W6
NLBNPIT1Z0W6 20991231 34...
EU
ESGFL
Euronext France ESG Lead...
EU
APHRG
Public Assitance Paris H...
BIT
P1W5K3
NLBNPIT1W5K3 20351221 4....
EU
BPCGW
BPCE Bpce5.86%15sep38
LBNK
THXUSDT
Thxcoin
EU
BNPHY
BNP Paribas 2.518% until...
BMF
TRYQ24
TRYQ24 - Agosto 2024
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유